Latest medical literature on fulvicin

Our library of drug research abstracts drawn from the medical literature is updated on a regular schedule, and you can be assured that new fulvicin research articles will be listed here shortly after becoming available to us.

Related Sponsors

Medical research on fulvicin

A comparison of Gris-PEG and Fulvicin-U/F in the treatment of tinea pedis.

J Am Podiatry Assoc. 1981 Jun; 71(6): 323-7
Kidawa AS, German CA

A multi-center, double-blind comparison of ketoconazole and griseofulvin in the treatment of infections due to dermatophytes.

Rev Infect Dis. 1980 Jul-Aug; 2(4): 586-91
Legendre R, Steltz M
The efficacy and safety of daily doses of 200 mg of ketoconazole or 250 mg of griseofulvin (Fulvicin-P/G, Schering, Kenilworth, N.J.) in the treatment of patients with infections due to dermatophytes are being evaluated in a three-center study. Patients with chronic dermatomycoses resistant to topical treatment or with infections that involve large areas of the body, a condition that indicates oral therapy, are being treated for a minimum of four weeks. Eleven (38%) of 29 patients treated with ketoconazole for four weeks and five (24%) of 21 patients treated with grisofulvin for the same amount of time were rated as cured. At completion of therapy (four to eight weeks), 24 (83%) of 29 patients treated with ketoconazole and six (32%) of 19 patients treated with griseofulvin were rated as cured (P = < 0.001). One (7%) of 14 patients treated with ketoconazole and four (80%) of five patients treated with griseofulvin were rated as relapsed within 28 days after completion of therapy (P = 0.006). No significant adverse effects have been reported for either treatment group. The preliminary results of this study have shown ketoconazole to be more effective than griseofulvin in the treatment of dermatomycoses.

Effect of griseofulvin (Fulvicin) in superficial fungous infections.

Nebr State Med J. 1961 Jan; 46: 10-4
CROTTY RQ

The use of fulvicin (griseofulvin) for superficial mycotic infections.

Bull Sch Med Univ Md. 1960 Apr; 45: 19-22
ROBINSON HM

Griseofulvin (fulvicin) in the treatment of fungous infections of the hair, skin and nails with special reference to mycologic changes produced during therapy.

J Invest Dermatol. 1960 Apr; 34: 263-9
REISS F, KORNBLEE L, GORDON B

Treatment of tinea with fulvicin (griseofulvin).

Ill Med J. 1960 Jan; 117: 1-5
NIERMAN MM, COHEN DM, GOLDEN M

Treatment of superficial fungous infections with fulvicin (griseofulvin).

J Indiana State Med Assoc. 1959 Oct; 52: 1771-4
NIERMAN MM, PILOT J